Brought to you by 
Neuronetics completes $30mm Series E financing
06 Jun 2011
Executive Summary
First-time backers Pfizer Venture Investments and Polaris Venture Partners have led a $30mm Series E financing for Neuronetics Inc., which creates magnetic pulse-generating devices for major depression. Existing shareholders Investor Growth Capital, New Leaf Venture Partners, InterWest Partners, Three Arch Partners, Quaker BioVentures, and Onset Ventures also participated. Polaris adds a new board member, and a director from Pfizer Venture will join as an observer.
Deal Industry
- Medical Devices
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Neuronetics completes $30mm Series E financing
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice